Pyrrolinone derivatives as a new class of P2X3 receptor antagonists. Part 3: Structure-activity relationships of pyrropyrazolone derivatives

Bioorganic & Medicinal Chemistry Letters
2020.0

Abstract

The P2X3 receptor is an attractive target for the treatment of pain and chronic coughing, and thus P2X3 antagonists have been developed as new therapeutic drugs. We previously reported selective P2X3 receptor antagonists by derivatization of hit compound 1. As a result, we identified hit compound 3, the structure of which was similar to hit compound 1. On the basis of SAR studies of hit compound 1, we modified hit compound 3 and compound 42 was identified as having analgesic efficacy by oral administration.

Knowledge Graph

Similar Paper

Pyrrolinone derivatives as a new class of P2X3 receptor antagonists. Part 3: Structure-activity relationships of pyrropyrazolone derivatives
Bioorganic & Medicinal Chemistry Letters 2020.0
Discovery and structure–activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor
Bioorganic & Medicinal Chemistry Letters 2010.0
Discovery and Structure Relationships of Salicylanilide Derivatives as Potent, Non-acidic P2X1 Receptor Antagonists
Journal of Medicinal Chemistry 2020.0
Design and synthesis of potent and selective P2X3 receptor antagonists derived from PPADS as potential pain modulators
European Journal of Medicinal Chemistry 2013.0
Synthesis and structure–activity relationships of carboxylic acid derivatives of pyridoxal as P2X receptor antagonists
Bioorganic & Medicinal Chemistry 2013.0
N-Substituted Phenoxazine and Acridone Derivatives: Structure–Activity Relationships of Potent P2X4 Receptor Antagonists
Journal of Medicinal Chemistry 2012.0
Carbamazepine derivatives with P2X4 receptor-blocking activity
Bioorganic & Medicinal Chemistry 2014.0
Synthesis and structure-activity relationships of quinolinone and quinoline-based P2X7 receptor antagonists and their anti-sphere formation activities in glioblastoma cells
European Journal of Medicinal Chemistry 2018.0
Structure–activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide
Bioorganic & Medicinal Chemistry 2009.0
Discovery of Novel 2,5-Dioxoimidazolidine-Based P2X<sub>7</sub>Receptor Antagonists as Constrained Analogues of KN62
Journal of Medicinal Chemistry 2015.0